Annual SG&A
$0.00$468.95M-100.00%
Summary
- Current Value
- As of today, NVAX annual SG&A is $0.00, down -100.00% on
- Historical Performance
- NVAX annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- NVAX annual SG&A is currently -100.00% below its historical high of $488.69M set on
- 3-Year Low Comparison
- NVAX annual SG&A vs 3-year low value is unknown
- Sector Comparison
- NVAX annual SG&A is higher than 39.46% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $31.66M | -55.3% | -74.2% | -44.4% | +1013.0% | |
| TTM SG&A | -$18.47B | -4559.8% | -4590.6% | -10000.0% | -10000.0% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual Operating Expenses | $716.19M | -36.0% | -74.6% | +452.6% | +1815.8% | |
| Annual Operating Profit | -$231.97M | +44.1% | +86.3% | -79.0% | -520.5% | |
| Annual D&A | $48.50M | +17.6% | +283.0% | +754.4% | +3961.6% | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $488.69M | N/A | -100.0% |
| 5Y | $488.69M | -100.0% | |
| All | $488.69M | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of NVAX?
As of today, NVAX annual SG&A is $0.00
What is 1-year change in NVAX annual SG&A?
NVAX annual SG&A is down -100.00% year-over-year
What is 3-year change in NVAX annual SG&A?
NVAX annual SG&A is down -100.00% over the past 3 years
How far is NVAX annual SG&A from its all-time high?
NVAX annual SG&A is currently -100.00% below its historical high of $488.69M set on December 31, 2022
How does NVAX annual SG&A rank versus sector peers?
NVAX annual SG&A is higher than 39.46% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly SG&A
$31.66M$11.96M-27.42%
Summary
- Current Value
- As of today, NVAX quarterly SG&A is $31.66M, down -27.42% on
- Historical Performance
- NVAX quarterly SG&A is down -55.26% year-over-year, and down -74.24% over the past 3 years
- All-Time High Comparison
- NVAX quarterly SG&A is currently -80.42% below its historical high of $161.66M set on
- 3-Year Low Comparison
- NVAX quarterly SG&A is at its 3-year low
- Sector Comparison
- NVAX quarterly SG&A is higher than 82.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $31.66M | -27.4% | -55.3% | -74.2% | -44.4% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | -$18.47B | -7769.4% | -4559.8% | -4590.6% | -10000.0% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly Operating Expenses | $130.05M | +9.0% | -16.4% | -69.0% | -32.7% | |
| Quarterly Operating Profit | -$79.40M | -175.1% | +38.8% | +37.6% | +58.9% | |
| Quarterly D&A | $6.59M | -12.9% | -48.1% | -21.1% | +455.2% | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $78.34M | N/A | -59.6% |
| 3Y | $161.66M | N/A | -80.4% |
| 5Y | $161.66M | -80.4% | |
| All | $161.66M | -80.4% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $31.66M | at low | |
| 3Y | $31.66M | at low | |
| 5Y | $31.66M | at low | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of NVAX?
As of today, NVAX quarterly SG&A is $31.66M
What is NVAX quarterly SG&A most recent change?
NVAX quarterly SG&A was down -27.42% on September 30, 2025
What is 1-year change in NVAX quarterly SG&A?
NVAX quarterly SG&A is down -55.26% year-over-year
How far is NVAX quarterly SG&A from its all-time high?
NVAX quarterly SG&A is currently -80.42% below its historical high of $161.66M set on December 31, 2022
How does NVAX quarterly SG&A rank versus sector peers?
NVAX quarterly SG&A is higher than 82.59% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM SG&A
-$18.47B$341.75M+1.82%
Summary
- Current Value
- As of today, NVAX TTM SG&A is -$18.47B, up +1.82% on
- Historical Performance
- NVAX TTM SG&A is down -4559.82% year-over-year, and down -4590.60% over the past 3 years
- All-Time High Comparison
- NVAX TTM SG&A is currently -81976.56% below its historical high of -$22.50M set on an earlier date
- 3-Year Low Comparison
- NVAX TTM SG&A is +6.31% above its 3-year low of -$19.71B reached on an earlier date
- Sector Comparison
- NVAX TTM SG&A is higher than 1.02% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$18.47B | -7769.4% | -4559.8% | -4590.6% | -10000.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $31.66M | -27.4% | -55.3% | -74.2% | -44.4% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| TTM Operating Profit | $416.73M | +13.8% | +243.7% | +134.0% | +260.3% | |
| TTM D&A | $35.01M | -14.9% | -25.2% | +37.3% | +770.1% | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$18.47B | N/A | at high |
| 3Y | -$15.71B | N/A | -17.6% |
| 5Y | -$6.53B | N/A | -182.9% |
| All | -$22.50M | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$19.71B | N/A | +6.3% |
| 3Y | -$19.71B | N/A | +6.3% |
| 5Y | -$19.71B | N/A | +6.3% |
| All | -$19.71B | N/A | +6.3% |
TTM SG&A History
FAQ
What is the current TTM SG&A of NVAX?
As of today, NVAX TTM SG&A is -$18.47B
What is NVAX TTM SG&A most recent change?
NVAX TTM SG&A was up +1.82% on September 30, 2025
What is 1-year change in NVAX TTM SG&A?
NVAX TTM SG&A is down -4559.82% year-over-year
How does NVAX TTM SG&A rank versus sector peers?
NVAX TTM SG&A is higher than 1.02% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax